US FDA modifies its list of medical device standards
This article was originally published in RAJ Devices
The US Food and Drug Administration has updated the list of medical device standards it uses in pre-market reviews. The list, which comprises the addition, withdrawal, correction and revision of certain consensus standards, is expected to help medical device manufacturers that elect to declare conformity with consensus standards meet certain requirements1.
You may also be interested in...
Swissmedic will scale back its review procedure for certain anti-infectives if the indications for which approval is being sought are identical to those approved in the EU or the US.
Based on the operational experience gained using the new international standard for reporting suspected adverse reactions in EudraVigilance, the EU has decided to set a date for its mandatory use.
The UK’s Health Research Authority has agreed in principle to implement a new policy that aims to drive a lasting change in clinical trial transparency. Not everyone is convinced.